Revascularization options in patients with chronic kidney disease.

Abstract

Cardiovascular disease is the leading cause of death in patients who have chronic kidney disease or end-stage renal disease and are undergoing hemodialysis. Chronic kidney disease is a recognized risk factor for premature atherosclerosis. Unfortunately, most major randomized clinical trials that form the basis for evidence-based use of revascularization… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.